At the end of this presentation, the participant will be able to:

• Review the currently recognized dose fractionations 
• Discuss the possibility of de-escalating brachytherpy dose in relation to tumor response
• Discuss the need to adapt applicator geometry in relation to tumor responsr during brachytherapy.